Organization · Corporate Venture Capital
Heala Ventures
Heala Ventures, also known as Sanara Capital, is a health-tech venture platform based in Israel, focusing on Digital Health, Bio-Convergence, and Medical Devices. The organization operates two funds, targeting A and B financing rounds for Israeli-related startups.
Overview
What Heala Ventures does
What Heala Ventures is
Heala Ventures, also known as Sanara Capital, is a health-tech venture platform based in Israel, focusing on Digital Health, Bio-Convergence, and Medical Devices. The organization operates two funds, targeting A and B financing rounds for Israeli-related startups.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Founded
- Founded in 2023
- Approximate age
- About 3 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Heala Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Heala Ventures as a funder
Investment thesis
Heala Ventures, also known as Sanara Capital, focuses on investing in health technology sectors, particularly Digital Health, Bio-Convergence, and Medical Devices, supporting innovative startups in these areas.
Focus narrative
Heala Ventures invests primarily in health technology sectors, with a strong emphasis on Digital Health, Bio-Convergence, and Medical Devices. The fund targets Series A and B financing rounds, focusing on startups that are innovating and making significant advancements in these areas.
Value beyond capital
Heala Ventures adds value to its portfolio companies through strategic support from its backers, Philips and Teva, providing access to commercial channels and industry expertise. The fund also offers a clear pathway for follow-on funding, enabling startups to secure additional capital as they grow.
Focus and fit
- Stages
- Seed · Series A · Series B
- Sectors
- Digital Health · Medical Devices
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
Portfolio context
Notable portfolio companies include: NanoDrops: Develops a pioneering technology for visual optical correction using a superficial laser imprint combined with eye drops. CVaid Medical: Focuses on advanced diagnostic tools for early stroke detection, utilizing an AI-based platform for stroke triage. Lydus Medical: Innovates in automated microvascular anastomosis for cardiovascular, transplant, and reconstructive microsurgery. QLog: Provides a digital platform aimed at improving operational readiness and workflow efficiency in healthcare facilities. Various other companies: The portfolio includes solutions for post-acute care connectivity, cerebral aneurysm treatment, venous stenosis, pediatric vision care, and food allergy management.
Common questions
What to know about Heala Ventures
Upseed classifies Heala Ventures under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.